These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38537944)

  • 21. Meningioma in patients exposed to progestin drugs: results from a real-life screening program.
    Samoyeau T; Provost C; Roux A; Legrand L; Dezamis E; Plu-Bureau G; Pallud J; Oppenheim C; Benzakoun J
    J Neurooncol; 2022 Oct; 160(1):127-136. PubMed ID: 36066786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiological evolution of progestogen-induced meningioma: A monocentric retrospective study.
    Ahmed-Khalifa T; Gillet R; Blonski M; Rech F; Fresse A; Gillet P; Taillandier L; Petitpain N
    Fundam Clin Pharmacol; 2023 Aug; 37(4):868-878. PubMed ID: 36692232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral and intrauterine progestogens for atypical endometrial hyperplasia.
    Luo L; Luo B; Zheng Y; Zhang H; Li J; Sidell N
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009458. PubMed ID: 30521671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progestogens for preventing miscarriage: a network meta-analysis.
    Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas.
    Apra C; Roblot P; Alkhayri A; Le Guérinel C; Polivka M; Chauvet D
    J Neurooncol; 2020 Aug; 149(1):95-101. PubMed ID: 32705456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential addition of low dose of medrogestone or medroxyprogesterone acetate to transdermal estradiol: a pilot study on their influence on the endometrium.
    Pansini F; De Paoli D; Albertazzi P; Bonaccorsi G; Campobasso C; Zanotti L; Pisati R; Giulini NA
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):137-41. PubMed ID: 8886696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience.
    Malaize H; Samoyeau T; Zanello M; Roux A; Benzakoun J; Peeters S; Zah-Bi G; Edjlali M; Tauziede-Espariat A; Dezamis E; Parraga E; Chrétien F; Varlet P; Plu-Bureau G; Oppenheim C; Pallud J
    J Neurooncol; 2021 Apr; 152(2):279-288. PubMed ID: 33449307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
    Naessen T; Olsson SE; Gudmundson J
    Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
    Schink T; Princk C; Braitmaier M; Haug U
    BJOG; 2022 Dec; 129(13):2107-2116. PubMed ID: 35876787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone.
    Shulman LP
    J Womens Health (Larchmt); 2006 Jun; 15(5):584-90. PubMed ID: 16796485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleeding patterns during continuous estradiol with different sequential progestogens therapy.
    Di Carlo C; Sammartino A; Di Spiezio Sardo A; Tommaselli GA; Guida M; Mandato VD; D'Elia A; Nappi C
    Menopause; 2005; 12(5):520-5. PubMed ID: 16145305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant.
    Piper JG; Follett KA; Fantin A
    Neurosurgery; 1994 Apr; 34(4):723-5; discussion 725. PubMed ID: 8008172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study.
    Nguyen P; Roland N; Neumann A; Hoisnard L; Passeri T; Duranteau L; Coste J; Froelich S; Zureik M; Weill A
    Lancet Reg Health Eur; 2024 Jul; 42():100928. PubMed ID: 38800110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use.
    Modesto W; de Nazaré Silva dos Santos P; Correia VM; Borges L; Bahamondes L
    Eur J Contracept Reprod Health Care; 2015 Feb; 20(1):57-63. PubMed ID: 25160484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas.
    Lee KS; Zhang JJY; Kirollos R; Santarius T; Nga VDW; Yeo TT
    Sci Rep; 2022 Feb; 12(1):1942. PubMed ID: 35121790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
    Raudaskoski T; Tapanainen J; Tomás E; Luotola H; Pekonen F; Ronni-Sivula H; Timonen H; Riphagen F; Laatikainen T
    BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference of gestagens and androgens with rat uterine oestrogen receptors.
    Di Carlo F; Conti G; Reboani C
    J Endocrinol; 1978 Apr; 77(1):49-55. PubMed ID: 147913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.